Affinia Therapeutics
Latest round
- Series C
Last raised
- Sep 2025
Total raised
- $163M
Investors
- 18
About Affinia Therapeutics
Founded in 2019 by Aaron Tward, Luk Vandenberghe, and Rob Aboud and based in Massachusetts, US, Affinia Therapeutics, Inc. is a gene therapy company with a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies. Rick Modi serves as the CEO of the company as of 2025. In September 2025, Affinia Therapeutics, Inc. The therapies can be used to overcome both tissue selectivity and immunogenicity and also to manufacture yields, and payload capacity. The company’s research relies on the use of synthetic and systems biology, combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases. The platform is used by medical professionals to achieve the rational design of novel vectors and gene therapies. Affinia Therapeutics, Inc. generates revenue by developing and licensing gene therapy programs using proprietary cardiotropic AAV capsid technology for rare genetic cardiac and neuromuscular diseases. In September 2025, Affinia Therapeutics, Inc.
Who invested in Affinia Therapeutics
18 investors across 3 rounds
See all investors in Affinia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Affinia Therapeutics
Who invested in Affinia Therapeutics?
Affinia Therapeutics has 18 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Affinia Therapeutics raised?
Affinia Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Affinia Therapeutics last raise money?
Affinia Therapeutics's most recent round on record is a Series C, in Sep 2025.
What does Affinia Therapeutics do?
Founded in 2019 by Aaron Tward, Luk Vandenberghe, and Rob Aboud and based in Massachusetts, US, Affinia Therapeutics, Inc.
Where is Affinia Therapeutics headquartered?
Affinia Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Affinia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Affinia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Affinia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.